Schedule 13G ownership disclosure

Cyclacel Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 23254L306

Event date: 2015-03-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,200,000
Percent of class
9.3100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-15-000049
Form type
SC 13G
Filer
Bio Green Med Solution, Inc.
CIK
CIK 1130166
Filed
Mar 10, 2015
Reporting period
Mar 04, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub